State Board of Administration of Florida Retirement System’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio KNTE Stock Details KNTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-14,254	Closed	-$89.1K	–	2426
2024 Q1	$89.1K	Buy	+14,254	New	+$35.3K	﹤0.01%	2080
2023 Q2	–	Sell	-14,254	Closed	-$89.1K	–	2534
2023 Q1	$89.1K	Hold	14,254	–	–	﹤0.01%	2169
2022 Q4	$86.9K	Sell	14,254 -5,050	-26%	-$41.1K	﹤0.01%	2228
2022 Q3	$231K	Hold	19,304	–	–	﹤0.01%	1997
2022 Q2	$243K	Buy	+19,304	New	+$180K	﹤0.01%	2033

State Board of Administration of Florida Retirement System's KNTE Position: Q2 2024 in Review

State Board of Administration of Florida Retirement System sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2024, closing a stake of 14,254 shares — an estimated $89.1K sold.

State Board of Administration of Florida Retirement System first reported a position in KNTE in Q2 2022 and held it in 5 quarters. The position peaked at $243K in Q2 2022. 0 funds tracked by Wall St. Rank hold KNTE as of Q2 2024.

State Board of Administration of Florida Retirement System reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
State Board of Administration of Florida Retirement System sold 14,254 Kinnate Biopharma Inc. Common Stock shares in Q2 2024, an estimated $89.1K.
State Board of Administration of Florida Retirement System first reported a position in Kinnate Biopharma Inc. Common Stock in Q2 2022 and held it in 5 quarters.
State Board of Administration of Florida Retirement System's Kinnate Biopharma Inc. Common Stock position peaked at $243K in Q2 2022.
0 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2024.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2024, filed 8 Aug 2024.